Dyronib 20 mg Tablet
  1. Home
  2. Pharma Products
  3. Hetero Healthcare Ltd
  4. Dyronib 20 mg Tablet

Dyronib 20 mg Tablet

Dyronib 20 mg Tablet contains dasatinib 20 mg and is an oral targeted anticancer medicine used to treat certain blood cancers. It is used for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia in appropriate patients. The tablet is a prescription medicine and should be taken under the supervision of an oncologist.

BUY NOW

Category

Dasatinib belongs to the tyrosine kinase inhibitor class and works by blocking abnormal proteins that signal leukemia cells to grow and multiply. It primarily targets BCR-ABL and other kinases involved in certain Philadelphia chromosome-positive leukemias. Regular blood tests and clinical monitoring may be required because treatment can affect blood-cell counts and may cause fluid retention, bleeding, or other adverse effects. The dose and treatment duration are determined by the treating physician according to the specific leukemia and individual treatment response.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 20 mg
Dosage Form Tablet
Pack Size 60 tablets
Route of Administration Oral
Marketer Hetero Healthcare Limited

Product Also Known As

Dyronib 20mg Tablet, Dyronib 20 mg Tablet, Dyronib 20 Tablet, Dasatinib 20mg Tablet, Dasatinib 20 mg Tablet, Dasatinib Oral Tablet, Dasatinib 20mg Anticancer Tablet